1Santagostino E,Morfini M,Rocino A,et al.Relationship between factor Ⅶ activity and clinical efficacy of recombinant factor Ⅶa given by continuous infusion to patients with factor Ⅷinhibitors.Thromb Haemost,2001,86:954-958.
2Negrier C,Goudemand J,Sultan Y,et al.Multicenter retrospective study on the utilization of FEIBA in France in patients with factor Ⅷ and factor Ⅸ inhibitors.French FEIBA Study Group.Factor Eight Bypassing Activity.Thromb Haemost,1997,77:1113-1119.
3Toepfler M,Rommel F,Sitter T,et al.Reduction of acquired high titer factor Ⅷ antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy.Thromb Haemost 1998,80:1035-1036.